1. A PHASE 2B STUDY OF SELINEXOR IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL). (12th June 2019) Authors: Kalakonda, N.; Cavallo, F.; Follows, G.; Goy, A.; Vermaat, J.; Casasnovas, O.; Lavee, O.; Maerevoet, M.; Zijlstra, J.; Bakshi, S.; Bouabdallah, R.; Choquet, S.; Gurion, R.; Hill, B.; Jaeger, U.; Sancho, J.; Schuster, M.; Thieblemont, C.; De la Cruz, F.; Egyed, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies. (24th July 2013) Authors: Gamaletsou, M. N.; Walsh, T. J.; Zaoutis, T.; Pagoni, M.; Kotsopoulou, M.; Voulgarelis, M.; Panayiotidis, P.; Vassilakopoulos, T.; Angelopoulou, M. K.; Marangos, M.; Spyridonidis, A.; Kofteridis, D.; Pouli, A.; Sotiropoulos, D.; Matsouka, P.; Argyropoulou, A.; Perloretzou, S.; Leckerman, K.; Mana... Journal: Clinical microbiology and infection Issue: Volume 20:Number 1(2014:Jan.) Page Start: O50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lenalidomide Induces Responses in Patients with MDS-DEL(5)Q Alone, or with One Additional Abnormality, Irrespective of Who Classification and Prognostic Categorization. (April 2017) Authors: Symeonidis, A.; Kouraklis-Symeonidis, A.; Galanopoulos, A.; Hatzimichael, E.; Zikos, P.; Vassilakopoulos, T.; Pappa, V.; Kotsianidis, I.; Dimou, M.; Palla, K.; Viniou, N.A.; Kartasis, Z.; Pontikoglou, C.; Barbarousi, D.; Pagoni, M.; Xanthopoulidis, G.; Kotsopoulou, M.; Michali, E.; Katodritou, E.... Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES. (23rd June 2022) Authors: Vassilakopoulos, T.; Ferhanoglu, B.; Horowitz, N. A.; Apostolidis, J.; Mellios, Z.; Kaynar, L.; Zektser, M.; Symeonidis, A.; Piperidou, A.; Kalpadaki, C.; Akay, O. M.; Atalar, S. C.; Sayyed, A.; Katodritou, E.; Leonidopoulou, T.; Papageorgiou, S.; Tadmor, T.; Gutwein, O.; Karakatsanis, S.; Ganzel... Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS. (23rd June 2022) Authors: Vassilakopoulos, T.; Piperidou, A.; Mellios, Z.; Verigou, E.; Kalpadakis, C.; Katodritou, E.; Papageorgiou, S.; Chatzidimitriou, C.; Giatra, C.; Leonidopoulou, T.; Xanthopoulos, V.; Karakatsanis, S.; Gainaru, G.; Vrakidou, E.; Koumarianou, A.; Hatzimichael, E.; Verrou, E.; Tsirogianni, M.; Dranda... Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: NOVEL PREDICTIVE INDICATORS IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC NEOPLASMS (HR-MDS) TREATED WITH 5-AZACYTIDINE: CUMULATIVE DATA FROM THE HELLENIC MDS STUDY GROUP. (May 2023) Authors: Kotsianidis, I.; Hatzimichael, E.; Pappa, V.; Galanopoulos, A.; Kourakli, A.; Diamantopoulos, P.; Papageorgiou, S.; Liapis, K.; Papadopoulos, V.; Papoutselis, M.; Bouchla, A.; Georgoulis, V.; Vassilakopoulos, T.; Solomou, E.; Dimou, M.; Vassilopoulos, G.; Vardi, A.; Papaioannou, M.; Pontikoglou, ... Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗